Current chemotherapeutic possibilities in the treatment of colorectal cancer
- 31 August 1995
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (7-8), 1193-1197
- https://doi.org/10.1016/0959-8049(95)00161-b
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Improving Adjuvant Therapy for Rectal Cancer by Combining Protracted-Infusion Fluorouracil with Radiation Therapy after Curative SurgeryNew England Journal of Medicine, 1994
- Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancerCancer, 1994
- Biologic agents as biochemical modulators: pharmacologic basis for the interaction of cytotoxic chemotherapeutic drugs and interferonCancer Chemotherapy and Pharmacology, 1994
- Cerebral Demyelination with 5-Fluorouracil and LevamisoleCancer Investigation, 1994
- Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy.Journal of Clinical Oncology, 1993
- The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.Journal of Clinical Oncology, 1993
- Adjuvant active specific immunotherapy for human colorectal cancer: 6.5-year median follow-up of a phase III prospectively randomized trial.Journal of Clinical Oncology, 1993
- Effective Surgical Adjuvant Therapy for High-Risk Rectal CarcinomaNew England Journal of Medicine, 1991
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancerCancer, 1989